Concord Drugs Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 14, 2017, to consider the following: 1. Un - Audited financial results for the quarter ended December 31, 2016. 2. Limited Review Report for the quarter ended December 31, 2016.

Pdf Link:Board Meeting Intimation for Results

Source : BSE - www.bseindia.com

comment COMMENT NOW